Transient recombinase system treatment of endothelial cells, differentiated from patient-derived induced pluripotent stem cells of a hemophilic donor, resulted in 12% correction of the inversion and restored Factor VIII mRNA expression.
[Nature Communications]
7992332
{7992332:DDDDDDDD}
apa
50
1
170942
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
